KBFS
GILD icon

Kohmann Bosshard Financial Services’s Gilead Sciences GILD Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-155
Closed -$19K – 359
2025
Q4 		$19K Buy
+155
New +$18.8K ﹤0.01% 746
2025
Q1 		– Sell
-4
Closed -$369 – 469
2024
Q4 		$369 Buy
+4
New +$360 ﹤0.01% 676

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Kohmann Bosshard Financial Services's GILD Position: Q1 2026 in Review

Kohmann Bosshard Financial Services sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 155 shares — an estimated $19K sold.

Kohmann Bosshard Financial Services first reported a position in GILD in Q4 2024 and held it in 2 quarters. The position peaked at $19K in Q4 2025. 2,332 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Kohmann Bosshard Financial Services reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 155 Gilead Sciences shares in Q1 2026, an estimated $19K.
  • Kohmann Bosshard Financial Services first reported a position in Gilead Sciences in Q4 2024 and held it in 2 quarters.
  • Kohmann Bosshard Financial Services's Gilead Sciences position peaked at $19K in Q4 2025.
  • 2,332 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2026, filed 23 Apr 2026.